Litcius/Paper detail

Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies

Liu Yang, Huan Lu, Wei Wang, Qi Liu, Changju Zhu

2020Expert Review of Anticancer Therapy43 citationsDOI

Abstract

INTRODUCTION: Patients with cancer are more vulnerable to COVID-19 than the general population. Accordingly, it is necessary to identify the risk factors for death in patients with cancer and COVID-19. METHODS: , 2020. Studies that explored the risk factors for mortality were included. The effect size was relative risk (RR) and 95% confidence interval (CI). RESULTS: < 0.05). CONCLUSIONS: Various demographic and clinical characteristics, such as male gender, advanced age, comorbidities, and symptoms, were risk factors for mortality in patients with cancer and COVID-19. Our findings suggest recent anti-cancer treatments do not increase mortality.

Topics & Concepts

MedicineInternal medicineObservational studyLung cancerCancerPopulationRelative riskCochrane LibraryConfidence intervalMeta-analysisCOPDEnvironmental healthCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesHealthcare cost, quality, practices
Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies | Litcius